Please use this identifier to cite or link to this item:
|Title:||TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells||Authors:||Hietakangas, V.
|Issue Date:||3-Oct-2008||Citation:||Hietakangas, V., Cohen, S.M. (2008-10-03). TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells. BMC Cancer 8 : -. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2407-8-282||Abstract:||Background: AKT signaling promotes cell growth, proliferation and survival and is hyperactivated in many cancers. TOR complex 2 (TORC2) activates AKT by phosphorylating it on the 'hydrophobic motif' site. Hydrophobic motif site phosphorylation is needed only for a subset of AKT functions. Whether proliferation of tumor cells depends on TORC2 activity has not been thoroughly explored. Methods: We used RNAi-mediated knockdown of rictor to inhibit TORC2 activity in MCF7 and PC3 tumor cells to analyze the importance of TORC2 on proliferation of tumor cells. Results: TORC2 inhibition reduced proliferation and anchorage-independent growth of both cell lines. Rictor depleted cells accumulated G1 phase, and showed prominent downregulation of Cyclin D1. Conclusion: This study provides further evidence that inhibition of TORC2 activity might be a useful strategy to inhibit proliferation of tumor cells and subsequent tumor growth. © 2008 Hietakangas and Cohen; licensee BioMed Central Ltd.||Source Title:||BMC Cancer||URI:||http://scholarbank.nus.edu.sg/handle/10635/130041||ISSN:||14712407||DOI:||10.1186/1471-2407-8-282|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 13, 2020
WEB OF SCIENCETM
checked on Jul 3, 2020
checked on Jul 11, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.